Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Enrolling and keeping participants in multiple sclerosis self-management interventions: A systematic review and meta-analysis.
The value of histopathological diagnosis in the elderly patients with granulomatous dermatoses. Case series.
Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in Tears.
Morphology of Donor and Recipient Nerves Utilised in Nerve Transfers to Restore Upper Limb Function in Cervical Spinal Cord Injury.
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.
The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis.
Anti-MAG autoantibodies are increased in Parkinson's disease but not in atypical parkinsonism.
Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.
Cognitive processess and cognitive reserve in multiple sclerosis.
Retinal Vascular Fractals Correlate With Early Neurodegeneration in Patients With Type 2 Diabetes Mellitus.
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab.
Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.
Walking impairs cognitive performance among people with multiple sclerosis but not controls.
Zinc transporter 3 (ZnT3) gene deletion reduces spinal cord white matter damage and motor deficits in a murine MOG-induced multiple sclerosis model.
Assessment of brain metabolite correlates of AAV-mediated overexpression of human alpha-synuclein in cortical neurons by in vivo(1) H-MR spectroscopy at 9.4 T.
The Pharmacokinetics and Dosing of Oral 4-Methylumbelliferone for Inhibition of Hyaluronan Synthesis in Mice.
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.
Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
Methylprednisolone microsphere sustained-release membrane inhibits scar formation at the site of peripheral nerve lesion.
Anesthetic management of a patient with multiple sclerosis - case report.
Obesity and Multiple Sclerosis: A Mendelian Randomization Study.
A more in-depth interpretation of MMPI-2 in MS patients by using Harris and Lingoes subscales.
Pages
« first
‹ previous
…
785
786
787
788
789
790
791
792
793
…
next ›
last »